Description
Product details
Nitrosmart 2.6 Controlled-Release Tablets Nitroglycerin 2.6 mg Nitrosmart 2.6 is a controlled-release cardiovascular medicine containing Nitroglycerin 2.6 mg. Nitroglycerin belongs to the organic nitrate group and is primarily used for the prevention and long-term management of angina pectoris in appropriately selected patients. The controlled-release formulation is designed to release Nitroglycerin gradually, providing a more sustained nitrate effect than rapid-acting formulations. Product Essentials Brand: Nitrosmart 2.6 Generic: Nitroglycerin Strength: 2.6 mg Formulation: Controlled-Release Tablet Drug Group: Organic Nitrate / Vasodilator Therapeutic Area: Anti-Anginal Therapy Route: Oral What Happens During Angina? Angina develops when the heart muscle's oxygen requirement exceeds the available oxygen supply, commonly in the setting of coronary artery disease. Nitroglycerin generates nitric oxide (NO) within vascular smooth muscle. Nitroglycerin → Nitric Oxide → Increased cGMP → Vascular relaxation Venodilation reduces venous return to the heart and lowers cardiac preload, which can decrease myocardial wall stress and oxygen demand. Why Use a Controlled-Release Form? Nitrosmart 2.6 is formulated for sustained nitrate delivery rather than immediate release. This makes an important clinical distinction: Controlled Release Designed for ongoing angina prevention according to the prescribed regimen. Rapid-Acting Nitrate Used when specifically prescribed for immediate relief of an acute angina attack. Therefore, Nitrosmart 2.6 should not automatically be relied upon as an emergency rescue medicine for sudden chest pain. What Patients May Notice Nitrate-related effects are often a direct consequence of vasodilation. Headache One of the most characteristic effects of nitrate therapy, particularly when treatment begins. Light-Headedness Blood-pressure reduction can cause dizziness, especially when standing suddenly. Flushing Widening of peripheral blood vessels may produce warmth or facial flushing. Low Blood Pressure Excessive vasodilation can occasionally produce significant hypotension or fainting. Critical Interaction: PDE-5 Inhibitors Nitroglycerin must not be combined with PDE-5 inhibitors used for erectile dysfunction or pulmonary hypertension, such as sildenafil, tadalafil, or vardenafil, because the combination can produce a dangerous fall in blood pressure. Concurrent use with riociguat is also contraindicated because of the risk of severe hypotension. Nitrate Tolerance Continuous exposure to organic nitrates can cause the body to become less responsive to their effects, a phenomenon known as nitrate tolerance. For this reason, nitrate treatment schedules may include an appropriate nitrate-free or low-nitrate interval when clinically indicated. The timing should be determined by the prescribing clinician rather than by skipping tablets independently. Controlled-Release Handling Because Nitrosmart 2.6 uses a modified-release system: Follow the product-specific administration instructions. Do not automatically crush or chew the tablet. Do not substitute it directly with an immediate-release Nitroglycerin formulation. Maintain the prescribed treatment schedule. Store according to the conditions printed on the pack. Frequently Asked Questions 1. What is Nitrosmart 2.6 used for? It is a controlled-release nitrate primarily associated with the prevention and management of angina when prescribed by a healthcare professional. 2. Is Nitrosmart 2.6 intended for immediate relief of sudden chest pain? A controlled-release tablet has a different purpose from rapid-acting nitrate formulations and should not automatically be used as an acute rescue treatment. 3. Why can Nitroglycerin cause headache? Headache is related to the medicine's vasodilating effect and is commonly associated with nitrate therapy. 4. Can Nitrosmart 2.6 cause dizziness? Yes. Vasodilation can reduce blood pressure and produce dizziness or light-headedness. 5. Can erectile-dysfunction medicines be used with Nitroglycerin? PDE-5 inhibitors such as sildenafil or tadalafil must not be combined with nitrates because severe hypotension can occur. 6. What is nitrate tolerance? It refers to reduced responsiveness after continuous nitrate exposure. Prescribed treatment schedules may be designed to minimize this effect. 7. Can a controlled-release tablet be crushed? It should not be crushed or altered unless the specific product information confirms this is acceptable, as doing so may interfere with controlled drug release. 8. Can Nitrosmart be stopped when angina improves? Treatment changes should be clinician-directed. Improvement may indicate that preventive therapy is effective rather than that it is no longer required.
